News
Study shows increase of Lyme disease in dogs
The condition in canines is rising in states traditionally not considered to be high-risk, suggesting human endangerment may also be increasing in these areas. Lyme disease in dogs has become increasingly common in the Northeast and has moved into U.S. regions not historically considered endemic. Full article
Read MoreUS Biologic/CAES Report Field Trials of Orally Delivered Anti-Lyme Vaccine Targeting the Field Mouse
The Connecticut Agricultural Experiment Station (CAES) and US Biologic announced the publication of field trials showing the effectiveness of the delivery of an orally-delivered anti-Lyme vaccine targeting the major wildlife source of Lyme disease, the white-footed mouse. Full article
Read MoreCAES Announces Field Trials Showing Impact of a Variety of Delivery Mechanisms for Zoonotic Disease Control
The Connecticut Agricultural Experiment Station (CAES) and US Biologic, Inc. announce today the publication of field trials showing the impact of delivery mechanisms to enhance future animal-borne (aka: zoonotic) disease control programs. Press release
Read MoreMason Kauffman of US Biologic on WKNO TV’s The Spark
The theme of The SPARK May 2020 is “Looking Out for Public Health.” Jeremy C. Park interviews Mason Kauffman of US Biologic, a Memphis-based company delivering disease prevention by providing orally delivered vaccines to address the world’s great health challenges.
Read MoreUS Biologic Broadens Intellectual Property Platform in Prevention of Zoonotic Disease
US Biologic, a leading oral vaccine and therapeutic delivery company, today announced that the United States Patent and Trademark Office has issued U.S. Patent #1065360 entitled “Composition & Method for Reducing Zoonotic Infectious Diseases.” The patent extends the US Biologic OrisBio™ oral-delivery technology platform in the creation of orally delivered vaccines. Press Release
Read MoreVaccinating Mice May Finally Slow Lyme Disease
Kirby Stafford, Connecticut’s state entomologist, knows only one surefire way to reduce tick populations enough to cut Lyme disease rates: killing deer. Otherwise, he says, “very little by itself really reduces tick numbers enough.” But in some Connecticut neighborhoods Stafford has been testing a new strategy, one he hopes might show real promise after years…
Read MoreLong-underfunded Lyme disease research gets an injection of money—and ideas
Months after a U.S. Congress–mandated working group sounded the alarm about tickborne illnesses and urged more federal action and money, the National Institutes of Health (NIH) is readying a strategic plan for these diseases. Last week it also, serendipitously, issued a rare solicitation for prevention proposals in tickborne diseases. The new pot of money, $6…
Read MoreThe Growing Global Battle Against Blood-Sucking Ticks
On a balmy day in late June, Scott Williams waits for a white-footed mouse (Peromyscus leucopus) to fall asleep. Williams, a wildlife biologist with the Connecticut Agricultural Experiment Station in New Haven, has just transferred the animal from a trap to a plastic bag containing a cotton ball doused in anaesthetic. As soon as the…
Read MoreDeadly Animal Diseases Can Jump to Humans. Is Vaccinating Wildlife the Answer?
Every January, planes dump one million small plastic packets covered in fishmeal crumbles along the Texas-Mexico border. When the sharp teeth of feral dogs or coyotes pierce the plastic, a liquid rabies vaccine squirts into their mouths. Full article
Read More“Major League” Researcher: Trela worked an internship at US Biologic this summer, holds a 4.0 GPA in biomedical engineering.
As part of his major, the shortstop needed an internship and was eager to complete one close to his second “home.” The senior, through Bumgardner, was connected with Dr. Jolieke van Oosterwijk, Chief Science Officer with an innovative biotech company called US Biologic located in downtown Memphis. The disease prevention company develops oral vaccines to…
Read More